Search results
HoneyNaps secures a $11.6 million Series B investment, becoming the No. 1 ranked A.I Sleep ...
Clearfield Progress· 8 hours agoHoneyNaps secures $11.6 million in series B funding, propelling its entry into the American medical market. BOSTON, May 24, 2024 /PRNewswire/ -- HoneyNaps ...
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29
Morningstar· 2 days agoBELGRADE, MT / ACCESSWIRE / May 22, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical < ...
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...
FOX 23 News Albany· 2 hours agoOncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, presented two abstracts at the 2024
INBS showcases drug screening tech at UK safety event By Investing.com
Investing.com· 7 days agoIntelligent Bio Solutions Inc. (NASDAQ:INBS), a medical technology company, announced today its...
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
Morningstar· 1 day ago(NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it has engaged Aagami, Inc.
Factbox-Some of the biggest splits in Corporate America
Reuters via Yahoo Finance· 19 hours agoThe new company is called Warner Bros ...
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma...
Benzinga· 19 hours agoThe Biden administration has urged the U.S. Supreme Court to reconsider a ruling involving 21...
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Position Trimmed by BI Asset Management Fondsmaeglerselskab...
ETF DAILY NEWS· 1 day ago(NYSE:ZBH – Free Report) by 57.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 6,687 shares of the medical equipment provider’s stock after selling ...
...Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical...
WROC Rochester· 16 hours agoAadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on...
Infinitus Systems Inc. launches AI instant benefit verification solution for Medicare Part B |...
Healthcare Dive· 3 days agoInfinitus Systems, Inc., the healthcare AI company that automates the collection of data traditionally gathered via...today announced an instantaneous, proprietary digital ...